From our private database of 33,600+ case briefs...
Chicago v. Purdue Pharma LP
United States District Court for the Northern District of Illinois
2015 WL 2208423 (2017)
In 1970, the federal government began to regulate opioid painkiller drugs as controlled substances with black-box labels warning about the potential for addiction and fatal overdose. In the 1970s and 1980s, the generally accepted medical-practice standards required that opioids be used only short-term for issues like acute pain, surgical-recovery pain, cancer, or palliative care. In the 1990s, Purdue Pharma LP and other pharmaceutical companies (pharmaceutical companies) (defendants) manufactured, promoted, and sold opioid painkillers, including OxyContin and Dilaudid, in the City of Chicago (the city) (plaintiff). The Food and Drug Administration (FDA) required the approval of drug labels and promotional materials. However, the FDA did not usually review unbranded promotional materials that promoted a type of drug without identifying a particular drug by name. The pharmaceutical companies sought to avoid FDA regulation by creating a network of front groups to promote chronic-pain treatment with opioid products through unbranded promotional materials that used deception, consumer fraud, false pretense, false promise, and misrepresentation. The city brought suit, claiming that the pharmaceutical companies’ unbranded promotional materials promoting the use of opioid painkiller drugs violated the Chicago Municipal Code (the city code), which prohibited consumer fraud and deceptive business practices. The city also claimed that it paid the pharmaceutical companies for unnecessarily prescribed opioid drugs for off-label purposes under false pretenses through employee health plans in violation of the city code. The pharmaceutical companies moved to dismiss the city-code claims.
Rule of Law
Holding and Reasoning (Alonso, J.)
What to do next…
Unlock this case brief with a free (no-commitment) trial membership of Quimbee.
You’ll be in good company: Quimbee is one of the most widely used and trusted sites for law students, serving more than 603,000 law students since 2011. Some law schools—such as Yale, Berkeley, and Northwestern—even subscribe directly to Quimbee for all their law students.Unlock this case briefRead our student testimonials
Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school.
Quimbee is a company hell-bent on one thing: helping you get an “A” in every course you take in law school, so you can graduate at the top of your class and get a high-paying law job. We’re not just a study aid for law students; we’re the study aid for law students.Learn about our approachRead more about Quimbee
Here's why 603,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 33,600 briefs, keyed to 984 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.